Peptide therapy on TikTok: separating hype from actual evidence

What did @hectorfitnesss actually say?

The creator described 5-amino-1MQ as a compound that blocks NNMT (nicotinamide N-methyltransferase), which in turn raises NAD+ levels and activates SIRT1, a gene he called "the longevity gene." He claimed this mechanism makes 5-amino-1MQ ideal for fat loss while preserving muscle, and that it reduces the chances of obesity, diabetes, and cardiovascular, liver, and kidney disease. He then disclosed that he sells 50 mg capsules of the compound, framing the dose as what "other people do" while stopping short of a direct recommendation. The combination of mechanistic explanation and product pitch in the same video deserves a close look.

Does the science back this up?

The basic biochemistry is real, but the leap from mouse studies to human fat-loss claims is a significant one. Most of what we know about 5-amino-1MQ comes from preclinical research, and that gap matters enormously when you're selling capsules to a 12,000-view TikTok audience.

The NNMT-blocking mechanism is real and documented. Hong et al. (2015, Biochemical and Biophysical Research Communications) identified NNMT as a regulator of adipocyte differentiation and energy metabolism. Kraus et al. (2014, Nature) demonstrated that lowering NNMT activity in mice improved metabolic function and reduced fat mass. The connection between NNMT inhibition and NAD+ availability is also supported by Ryu et al. (2018, Nature Communications), who showed that NNMT consumes methyl groups that would otherwise support NAD+ synthesis pathways.

SIRT1 is a real sirtuin protein with documented roles in metabolic regulation. Guarente (2011, Genes and Development) reviewed SIRT1's involvement in energy sensing and its links to caloric restriction pathways. Calling it "the longevity gene" is a simplification, but not a fabrication. The problem is that none of these studies were conducted in humans using oral 5-amino-1MQ capsules at any dose.

What did they get wrong (or right)?

Credit where it's due: the core mechanism the creator described, NNMT inhibition raising NAD+ and activating SIRT1, is directionally consistent with published preclinical literature. That's more than many supplement influencers bother to get right.

But the claims about reducing "chances of obesity, diabetes, and cardiovascular, liver, and kidney disease" go well beyond what the evidence supports for humans. Those associations come from SIRT1 pathway research in animal models and observational studies, not from clinical trials of 5-amino-1MQ as an intervention. The FDA has not approved 5-amino-1MQ for any indication. There are no published Phase II or Phase III human trials on this compound.

• The claim that it's "perfect for allowing your body to burn fat for fuel" while preserving muscle is unverified in humans.
• Describing it as "amazing at reducing diet-related obesity" implies an efficacy that no human trial has established.
• Saying "I cannot give specific recommendations" and then immediately disclosing a 50 mg dose of his own product is a transparency problem, not a disclaimer.

What should you actually know?

5-amino-1MQ is a research chemical, not a regulated supplement or approved drug. Anyone selling it is operating in a gray market, and anyone buying it is taking on unknown risk. The preclinical science is interesting, but interesting preclinical science describes thousands of compounds that never panned out in humans.

NAD+ precursors like NMN and NR have more human trial data than 5-amino-1MQ and are still considered investigational for most metabolic claims. If the indirect pathway has this much uncertainty, the upstream compound has even more. Yoshino et al. (2021, Science) published one of the more rigorous NMN human trials and found modest metabolic effects in a specific population, which tells you how hard it is to translate this mechanism into meaningful human outcomes.

The cost argument, "this product is definitely not cheap to make," is a sales technique, not a safety or efficacy signal. Price does not validate a compound. If you're considering any unapproved peptide or research chemical for metabolic purposes, the conversation should start with a licensed clinician who can review your full health picture, not a TikTok video tied to a product sale.